"The US Court of Appeals for the Federal Circuit's recent precedential decision in GlaxoSmithKline v. Teva Pharmaceuticals USA has potentially far-reaching impacts in cases involving allegations of induced infringement."
Read the article (subscription required)
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
